Authors:
FIELDS KK
ELFENBEIN GJ
PERKINS JB
BALLESTER OF
GOLDSTEIN SC
HEIMENZ JW
SAEZ RA
SULLIVAN DM
PARTYKA JS
KRONISH LA
Citation: Kk. Fields et al., DEFINING THE ROLE OF NOVEL HIGH-DOSE CHEMOTHERAPY REGIMENS FOR THE TREATMENT OF HIGH-RISK BREAST-CANCER, Seminars in oncology, 25(2), 1998, pp. 1-6
Authors:
JANSSEN WE
ELFENBEIN GJ
PARTYKA JS
FIELDS KK
Citation: We. Janssen et al., RECOVERY OF GRANULOCYTE AND PLATELET COUNTS AFTER AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IS DETERMINED BY TRANSPLANT REGIMEN, MOBILIZING REGIMEN CD34(+) CELL COUNT, Experimental hematology, 25(8), 1997, pp. 306-306
Authors:
ELFENBEIN GJ
SINGH B
KRONISH LE
PERKINS JB
FIELDS KK
Citation: Gj. Elfenbein et al., HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION PROVIDES PALLIATION FOR WOMEN WITH HIGH-RISK BREAST-CANCER WHO ARE NOT CURED BY THE TRANSPLANT, Experimental hematology, 25(8), 1997, pp. 321-321
Authors:
BALLESTER OF
TUMMALA R
JANSSEN WE
FIELDS KK
HIEMENZ JW
GOLDSTEIN SC
PERKINS JB
SULLIVAN DM
ROSEN R
SACKSTEIN R
ZORSKY P
SAEZ R
ELFENBEIN GJ
Citation: Of. Ballester et al., HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE-MYELOMA AND RENAL-INSUFFICIENCY, Bone marrow transplantation, 20(8), 1997, pp. 653-656
Authors:
BALLESTER OF
MOSCINSKI LC
FIELDS KK
HIEMENZ JW
ZORSKY PE
GOLDSTEIN SC
SABA HI
SPIERS ASD
KRONISH L
SULLIVAN P
ELFENBEIN GJ
Citation: Of. Ballester et al., DEXAMETHASONE, CYCLOPHOSPHAMIDE, IDARUBICIN AND ETOPOSIDE (DC-IE) - ANOVEL, INTENSIVE INDUCTION CHEMOTHERAPY REGIMEN FOR PATIENTS WITH HIGH-RISK MULTIPLE-MYELOMA, British Journal of Haematology, 96(4), 1997, pp. 746-748
Authors:
ELFENBEIN GJ
PARTYKA JS
PERKINS JB
JANSSEN WE
FIELDS KK
Citation: Gj. Elfenbein et al., WHAT DETERMINES THE PACE OF RECOVERY OF GRANULOCYTE AND PLATELET COUNTS AFTER AUTOLOGOUS TRANSPLANTATION OF PERIPHERAL-BLOOD STEM-CELL COLLECTED AFTER MOBILIZATION WITH CHEMOTHERAPY AND G-CSF, Blood, 90(10), 1997, pp. 1651-1651
Authors:
AGALIOTIS DP
BALLESTER OF
MATTOX T
HIEMENZ JW
FIELDS KK
ZORSKY PE
GOLDSTEIN SC
PERKINS JB
ROSEN RM
ELFENBEIN GJ
Citation: Dp. Agaliotis et al., NEPHROTOXICITY OF HIGH-DOSE IFOSFAMIDE CARBOPLATIN/ETOPOSIDE IN ADULTS UNDERGOING AUTOLOGOUS STEM-CELL TRANSPLANTATION/, The American journal of the medical sciences, 314(5), 1997, pp. 292-298
Authors:
SACKSTEIN R
FU L
ALLEN KL
JANSSEN WE
ELFENBEIN GJ
Citation: R. Sackstein et al., DETECTION OF A NOVEL L-SELECTIN LIGAND ON NORMAL HUMAN HEMATOPOIETIC PROGENITOR CELLS, Journal of investigative medicine, 44(3), 1996, pp. 215-215
Authors:
MOSCINSKI LC
TRUDEAU WL
FIELDS KK
ELFENBEIN GJ
Citation: Lc. Moscinski et al., HIGH-SENSITIVITY DETECTION OF MINIMAL RESIDUAL BREAST-CARCINOMA USINGTHE POLYMERASE CHAIN-REACTION AND PRIMERS FOR CYTOKERATIN-19, Diagnostic molecular pathology, 5(3), 1996, pp. 173-180
Citation: Jr. Wingard et Gj. Elfenbein, HOST IMMUNOLOGICAL AUGMENTATION FOR THE CONTROL OF INFECTION, Infectious disease clinics of North America, 10(2), 1996, pp. 345
Authors:
SACKSTEIN R
FU L
ALLEN KL
JANSSEN WE
ELFENBEIN GJ
Citation: R. Sackstein et al., A NOVEL L-SELECTIN LIGAND IS EXPRESSED ON NORMAL HUMAN HEMATOPOIETIC PROGENITOR CELLS, Experimental hematology, 24(9), 1996, pp. 295-295
Authors:
BALLESTER OF
AGALIOTIS DP
HIEMENZ JW
JANSSEN WE
FIELDS KK
ZORKSY PE
GOLDSTEIN SC
PERKINS JB
ELFENBEIN GJ
Citation: Of. Ballester et al., PHASE I-II STUDY OF HIGH-DOSE BUSULFAN AND CYCLOPHOSPHAMIDE FOLLOWED BY AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES - TOXICITIES AND HEMATOPOIETIC RECOVERY, Bone marrow transplantation, 18(1), 1996, pp. 9-14
Citation: Jb. Perkins et al., ANALYSIS OF DOSE-RESPONSE RELATIONSHIPS IN THE SETTING OF HIGH-DOSE IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION - IMPLICATIONS FOR THE TREATMENT OF PATIENTS WITH ADVANCED BREAST-CANCER, Seminars in oncology, 23(3), 1996, pp. 42-46
Authors:
ELFENBEIN GJ
PERKINS JB
JANSSEN WE
PARTYKA JS
FIELDS KK
Citation: Gj. Elfenbein et al., RECOVERY OF HEMATOPOIESIS AFTER HIGH-DOSE THERAPY AND AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IS CLEARLY DEPENDENT UPON THE MOBILIZING REGIMEN AND THE TRANSPLANT REGIMEN, Blood, 88(10), 1996, pp. 1618-1618
Citation: R. Sackstein et al., IN-VITRO ADHERENCE OF LYMPHOCYTES TO DERMAL ENDOTHELIUM IS A MARKER FOR ACUTE CUTANEOUS GVHD, Blood, 88(10), 1996, pp. 1674-1674
Citation: Dp. Agaliotis et al., CASE-REPORT OF SPONTANEOUS REMISSION OF CYTOGENETIC RELAPSE OF CHRONIC MYELOGENOUS-LEUKEMIA SUGGESTIVE OF PROGRESSION TO BLAST CRISIS AFTERALLOGENEIC BONE-MARROW TRANSPLANTATION, Annals of hematology, 70(1), 1995, pp. 37-41
Citation: Kk. Fields et al., HIGH-DOSE IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE WITH AUTOLOGOUS STEM-CELL SUPPORT - REPLY, Journal of clinical oncology, 13(7), 1995, pp. 1826-1827
Authors:
FIELDS KK
ELFENBEIN GJ
LAZARUS HM
COOPER BW
PERKINS JB
CREGER RJ
BALLESTER OF
HIEMENZ JH
JANSSEN WE
ZORSKY PE
Citation: Kk. Fields et al., MAXIMUM-TOLERATED DOSES OF IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE GIVEN OVER 6 DAYS FOLLOWED BY AUTOLOGOUS STEM-CELL RESCUE - TOXICITY PROFILE, Journal of clinical oncology, 13(2), 1995, pp. 323-332
Authors:
PERKINS JB
ELFENBEIN GJ
JANSSEN WE
FIELDS KK
BALLESTER OF
HIEMENZ JW
ZORSKY PE
GOLDSTEIN SC
Citation: Jb. Perkins et al., LACK OF DIFFERENCE IN RATE OF HEMATOPOIETIC RECOVERY AFTER BONE-MARROW AND PERIPHERAL-BLOOD STEM-CELL INFUSION VERSUS PERIPHERAL-BLOOD STEM-CELLS ALONE, Experimental hematology, 23(8), 1995, pp. 761-761
Citation: Kk. Fields et al., CYTOKERATIN-19 IN BONE-MARROW DETECTED BY POLYMERASE CHAIN-REACTION PREDICTS RELAPSES IN PATIENTS WITH CHEMORESPONSIVE METASTATIC BREAST-CANCER UNDERGOING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL RESCUE, Experimental hematology, 23(8), 1995, pp. 785-785
Authors:
JANSSEN WE
SMILEE RC
PERKINS J
FIELDS J
HIEMENZ KK
ZORSKY JW
BALLESTER PE
GOLDSTEIN OF
KRONISH SC
BEACH B
ELFENBEIN GJ
Citation: We. Janssen et al., PLATELET AND NEUTROPHIL RECOVERY FOLLOWING AUTOTRANSPLANT WITH G-CSF PRIMED MARROW OR G-CSF MOBILIZED BLOOD IS NOT DIFFERENT, Experimental hematology, 23(8), 1995, pp. 863-863
Authors:
NEMUNAITIS J
ROSENFELD CS
ASH R
FREEDMAN MH
DEEG HJ
APPELBAUM F
SINGER JW
FLOMENBERG N
DALTON W
ELFENBEIN GJ
RIFKIN R
RUBIN A
AGOSTI J
HAYES FA
HOLCENBERG J
SHADDUCK RK
Citation: J. Nemunaitis et al., PHASE-III RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF RHGM-CSF FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 15(6), 1995, pp. 949-954
Citation: Jb. Perkins et al., IFOSFAMIDE CARBOPLATIN/ETOPOSIDE CHEMOTHERAPY FOR METASTATIC BREAST-CANCER WITH OR WITHOUT AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION - EVALUATION OF DOSE-RESPONSE RELATIONSHIPS/, Seminars in oncology, 22(3), 1995, pp. 5-8
Authors:
FIELDS KK
ELFENBEIN GJ
MOSCINSKI LC
TRUDEAU WL
JANSSEN WE
Citation: Kk. Fields et al., PCR DETECTION OF BREAST-CANCER CELLS IN PERIPHERAL-BLOOD STEM-CELL COLLECTIONS - INCIDENCE AND CORRELATIONS, Blood, 86(10), 1995, pp. 2484-2484